Website Terms of Use      Privacy Policy      Cookie Policy     Copyright HGF © 2021 All Rights Reserved.

Copyright HGF © 2021 All Rights Reserved.

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and nanobodies, as well as CAR-T and CAR-NK cells may represent an important aspect for a company’s intellectual property position...

READ ARTICLE

By Linda Huber & Ellie Purnell

Healthcare Scanner

NEWS & EVENTS

Issue 4 - June 2022

Welcome to Issue 4 of the HGF Healthcare Scanner, a regular newsletter from HGF covering IP news and issues in the healthcare sector.

In this issue we are very happy that Linda Huber (Nixon Peabody) has contributed to a joint article with Ellie Purnell (HGF) giving a comparison on patenting antibodies in the USA and Europe. Claire Jones explains how 3D shape trade marks might add useful protection for medical devices. Janine Swarbrick gives an overview of patenting AI inventions in the healthcare field, and Cassandra Smith explores patenting of digital mental health inventions. Finally, Katie Goulding looks at the overlap of trade mark classes for functional foods and nutraceuticals, and offers some tips on how to avoid issues.

Innovation in medical devices continues strongly and the introduction of IoT and 3D printing (amongst others) has led to an acceleration in new medical devices. Whilst patents and designs are the obvious routes to protect medical devices, consideration should also be given to 3D shape trade marks...

READ ARTICLE

By Claire Jones 

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis and calculations much faster and more accurately than an expert human, including in the field of healthcare...

READ ARTICLE

By Dr Janine Swarbrick

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder. Monitoring and managing mental health conditions poses a unique set of problems for clinicians, researchers, and patients...

READ ARTICLE

By Dr Cassie Smith

Food-pharma industry convergence is not a new development. In 2013, a study of the patent citation data of 274 published European patents by 5 EU Medical Nutrition companies revealed the blurring of lines between conventional food and pharmaceuticals and concluded that pharmaceutical technologies were driving medical nutrition innovation...

READ ARTICLE

By Katie Goulding